Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 114

1.

Prediction of Locally Advanced Urothelial Carcinoma of the Bladder Using Clinical Parameters before Radical Cystectomy - A Prospective Multicenter Study.

Martini T, Aziz A, Roghmann F, Rink M, Chun FK, Fisch M, Trojan L, Hakenberg OW, Zastrow S, Wirth MP, Moersdorf J, Brookman-May S, Stief CG, Haferkamp A, Wagenlehner F, Hohenfellner M, Herrmann E, Lusuardi L, Grimm MO, Müller SC, Roigas J, Bastian PJ, Gierth M, Burger M, Pycha A, Seitz C, May M, Bolenz C.

Urol Int. 2015 Jul 1. [Epub ahead of print]

PMID:
26139354
2.

Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study.

Kübler H, Scheel B, Gnad-Vogt U, Miller K, Schultze-Seemann W, Vom Dorp F, Parmiani G, Hampel C, Wedel S, Trojan L, Jocham D, Maurer T, Rippin G, Fotin-Mleczek M, von der Mülbe F, Probst J, Hoerr I, Kallen KJ, Lander T, Stenzl A.

J Immunother Cancer. 2015 Jun 16;3:26. doi: 10.1186/s40425-015-0068-y. eCollection 2015.

3.

Increased expression of CYP17A1 indicates an effective targeting of the androgen receptor axis in castration resistant prostate cancer (CRPC).

Bremmer F, Jarry H, Strauß A, Behnes CL, Trojan L, Thelen P.

Springerplus. 2014 Oct 1;3:574. doi: 10.1186/2193-1801-3-574. eCollection 2014.

4.

[Antibiotic resistance in nontyphoidal salmonellae serovars in the Czech Republic].

Zemličková H, Dědičová D, Jakubů V, Mach J, Kolínská R, Malíková E, Urbášková P, Adámková V, Bartoniková N, Bártová M, Bendová E, Bergerová T, Bohunová Z, Čápová E, Dovalová M, Glasnák M, Hanslianová M, Hásková H, Heinigeová B, Hermanová N, Horníková M, Horová B, Chmelařová E, Janečková J, Ježek P, Jindrák V, Kohnová I, Kolářová L, Krčková D, Kůrková V, Linhart P, Machučová M, Miklová J, Niemczyková J, Nyč O, Ochvatová B, Ouertani A, Paterová P, Pokorná Z, Pomykal J, Sekáčová A, Scharfen J, Skačáni H, Steinerová A, Šimečková E, Štolbová M, Tejkalová R, Trojan L, Uhlířová E, Vašková L, Vesela E, Zálabská E, Zamazalová D, Záruba R, Železná J.

Epidemiol Mikrobiol Imunol. 2013 Jul;62(2):43-9. Czech.

PMID:
23964964
5.

Testosterone boosts for treatment of castration resistant prostate cancer: an experimental implementation of intermittent androgen deprivation.

Thelen P, Heinrich E, Bremmer F, Trojan L, Strauss A.

Prostate. 2013 Nov;73(15):1699-709. doi: 10.1002/pros.22711. Epub 2013 Jul 19.

PMID:
23868789
6.

Relaxed imprinting of IGF2 in peripheral blood cells of patients with a history of prostate cancer.

Belharazem D, Kirchner M, Geissler F, Bugert P, Spahn M, Kneitz B, Riedmiller H, Sauer C, Küffer S, Trojan L, Bolenz C, Michel MS, Marx A, Ströbel P.

Endocr Connect. 2012 Oct 24;1(2):87-94. doi: 10.1530/EC-12-0054. Print 2012 Nov 1.

7.

Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.

Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M.

World J Urol. 2014 Apr;32(2):365-71. doi: 10.1007/s00345-013-1105-4. Epub 2013 Jun 5.

PMID:
23736527
8.

During twenty years of Cisplatin-based therapy the face of nonseminomatous testicular germ cell tumors is still changing: an evaluation of presentation, management, predictive factors and survival.

Heinzelbecker J, Katzmarzik M, Weiss C, Trojan L, Haecker A.

Int Braz J Urol. 2013 Jan-Feb;39(1):10-21. doi: 10.1590/S1677-5538.IBJU.2013.01.03.

9.

Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.

Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ.

Eur J Surg Oncol. 2013 Apr;39(4):372-9. doi: 10.1016/j.ejso.2013.02.009.

PMID:
23465180
10.

Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.

Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M.

Gend Med. 2012 Dec;9(6):481-9. doi: 10.1016/j.genm.2012.11.001.

PMID:
23217567
11.

The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors.

Heinzelbecker J, Gropp T, Weiss C, Huettl K, Stroebel P, Haecker A, Bolenz C, Trojan L.

Urol Oncol. 2014 Feb;32(2):178-85. doi: 10.1016/j.urolonc.2012.08.004. Epub 2012 Nov 7.

PMID:
23141777
12.

Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programme.

Heidenreich A, Scholz HJ, Rogenhofer S, Arsov C, Retz M, Müller SC, Albers P, Gschwend J, Wirth M, Steiner U, Miller K, Heinrich E, Trojan L, Volkmer B, Honecker F, Bokemeyer C, Keck B, Otremba B, Ecstein-Fraisse E, Pfister D.

Eur Urol. 2013 Jun;63(6):977-82. doi: 10.1016/j.eururo.2012.08.058. Epub 2012 Sep 3.

PMID:
23116658
13.

Leiomyoma of the tunica albuginea, a case report of a rare tumour of the testis and review of the literature.

Bremmer F, Kessel FJ, Behnes CL, Trojan L, Heinrich E.

Diagn Pathol. 2012 Oct 9;7:140. doi: 10.1186/1746-1596-7-140. Review.

14.

The lymphatic system in clinically localized urothelial carcinoma of the bladder: morphologic characteristics and predictive value.

Bolenz C, Auer M, Ströbel P, Heinzelbecker J, Schubert C, Trojan L.

Urol Oncol. 2013 Nov;31(8):1606-14. doi: 10.1016/j.urolonc.2012.02.012. Epub 2012 Apr 13.

PMID:
22503575
15.

Radical prostatectomy after previous transurethral resection of the prostate: robot-assisted laparoscopic versus open radical prostatectomy in a matched-pair analysis.

Martinschek A, Heinzelmann K, Ritter M, Heinrich E, Trojan L.

J Endourol. 2012 Sep;26(9):1136-41. doi: 10.1089/end.2012.0074. Epub 2012 May 31.

PMID:
22489895
16.

External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder.

Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, Wülfing C, May F, Melchior S, Haferkamp A, Gilfrich C, Hohenfellner M, Wieland WF, Müller SC, Stief CG, Bastian PJ.

Eur J Surg Oncol. 2012 Jul;38(7):637-42. doi: 10.1016/j.ejso.2012.02.187. Epub 2012 Mar 27.

PMID:
22459902
17.

Methodology for Anti-Gene Anti-IGF-I Therapy of Malignant Tumours.

Trojan J, Pan YX, Wei MX, Ly A, Shevelev A, Bierwagen M, Ardourel MY, Trojan LA, Alvarez A, Andres C, Noguera MC, Briceno I, Aristizabal BH, Kasprzak H, Duc HT, Anthony DD.

Chemother Res Pract. 2012;2012:721873. doi: 10.1155/2012/721873. Epub 2012 Feb 14. Erratum in: Chemother Res Pract. 2012;2012:765703.

18.

External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder.

May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M.

J Urol. 2012 Apr;187(4):1210-4. doi: 10.1016/j.juro.2011.11.104. Epub 2012 Feb 14.

PMID:
22335861
19.

Novel options for the treatment of castration-resistant prostate cancer.

Ohlmann CH, Merseburger AS, Suttmann H, Schilling D, Trojan L, Kempkensteffen C, Corvin S, Mathers MJ, Bastian PJ.

World J Urol. 2012 Aug;30(4):495-503. doi: 10.1007/s00345-011-0796-7. Epub 2011 Nov 20. Review.

PMID:
22101903
20.

Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a.

May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Wieland WF, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Nuhn P, Burger M.

Urol Oncol. 2013 Oct;31(7):1141-7. doi: 10.1016/j.urolonc.2011.09.011. Epub 2011 Nov 6.

PMID:
22056404
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk